Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7417 p308
9 September 2006

This article
Reprint   Photocopy

PDF 40K, Acrobat Reader

Letters

· The Society
· Community pharmacy
· Control of entry
· Complementary medicine
· Controlled drugs
· Diabetes
· Pharmacy in the US


Letters to the Editor

Controlled drugs

We are there to safeguard the public

From Dr B. P. Curwain, MRPharmS

Beverley Stephens (PJ, 26 August, p247) is right to point out that GPs are still able to purchase Controlled Drugs on signed orders as in the past. However I take issue with her suggestion that this “loophole” makes the other changes a waste of time.

As professionals, pharmacists have a responsibility to ensure, where possible, that supplies they make are not being used for inappropriate purposes. For example, if a pharmacy were to receive signed orders for a total of 150 ampoules of diamorphine over a three-month period from one GP, and no other GP in the area was seeking supplies in this way, would it be correct simply to carry on supplying? Personally, I would be loath to do so, unless I could be persuaded that all was above board, and that I could stand up in front of the Statutory Committee and justify my actions. Once the Royal Pharmaceutical Society’s inspectors take over the role previously held by the police, we can be sure that they will ask questions when faced with unusual volumes or patterns of supply.

Just because a signed order or other document is legal does not mean that we are obliged to supply. As a locum, I have, after a discussion with the pharmacy owner, refused to dispense private prescriptions for large quantities of dihydrocodeine written by a retired doctor for his wife.

We are there to safeguard the public.

Brian Curwain
Chief Pharmacist and Research and Development Lead
New Forest Primary Care Trust

Send your letter to The Editor

Previous Topic (Complementary medicine)
Next Topic (Diabetes)

Back to Top


©The Pharmaceutical Journal